Newly developed injectable, adhesive surgical gel to prevent scar tissue

Up to 90% of patients who undergo open abdominal or pelvic surgery develop postoperative adhesions, or scar tissue. Minimally invasive laparoscopic surgical approaches can reduce the severity of the adhesions, but the scar tissue still forms. The cellular response to injury—even intentional injury, such as surgery to repair a problem—results in a cascade of molecules pouring to the site to heal the tissue. But the molecules, working quickly to close the wound, often go too far and bind the wound to nearby healthy tissue. Depending on the location, the resulting scar tissue can cause chronic pain, bowel obstruction and even death … read more

AmnioText from Regenative Labs

AmnioText™ patches are produced from human amniotic membranes and can be placed on the wound closure sites after a medical procedure or directly onto an open wound. The allografts are minimally manipulated and undergo an extensive and comprehensive testing process. The patches are produced in our first-class, state-of-the-art lab in Pensacola, Florida, to ensure the highest quality tissue allografts available. Click here to request more information